Antoine N. Saliba

Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients

Naseema Gangat, Omer Karrar, Moazah Iftikhar et al. · American Journal of Hematology · 2023 · 75 citations · Full text

Medicine, Hematology, Oncology +13

Impact of Resident Involvement in Surgery (IRIS-NSQIP): Looking at the Bigger Picture Based on the American College of Surgeons-NSQIP Database

Antoine N. Saliba, Alì Taher, Hani Tamim et al. · Journal of the American College of Surgeons · 2015 · 64 citations

Medicine, Medical Education, Surgery +12

Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Talha Badar, Ehab Atallah, Rory M. Shallis et al. · Leukemia · 2023 · 62 citations · Full text

Medicine, Hematology, Oncology +17

Preoperative INR and postoperative major bleeding and mortality: A retrospective cohort study

Hani Tamim, Antoine N. Saliba, Khaled M. Musallam et al. · Journal of Thrombosis and Thrombolysis · 2015 · 48 citations

Medicine, Perioperative Medicine, Surgery +16

Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia

Antoine N. Saliba, August John, Scott H. Kaufmann · Cancer Drug Resistance · 2020 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17